Differences in telomerase expression by the CDIa+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease

Journal of Pathology

Volumn 212, Issue 2, 2007, Pages 188-197

  da Costa, C E T ^a   Egeler, R M ^a   Hoogeboom, M ^a   Szuhai, K ^a   Forsyth, R G ^b   Niesters, M ^a   de Krijger, R R ^c   Tazi, A ^d   Hogendoom, P C W ^a   Annels, N E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Langerhans cell histiocytosis; Langerhans cells; Telomerase; Telomere length

Indexed keywords

CD1 ANTIGEN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; BIOPSY; BONE LESION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DEFECT; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANTIGENS, CD1; BONE AND BONES; CHILD; GIANT CELLS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; SKIN; TELOMERASE; TELOMERE;

EID: 34249776921     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2167     Document Type: Article

References (36)

1. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127(1):1-11.
2. Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM. Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol 2003;24(4):190-196.
3. Nezelof C, Basset F, Rousseau-Merck MF, Barbey S. [Dynamic studies of Langerhans cell histiocytosis cells. Their contribution to the current concept of the disease. Report of a series of 38 cases]. Bull Acad Natl Med 1999;183(4):815-822.
4. Arico M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, et al. Familial clustering of Langerhans cell histiocytosis. Br J Haematol 1999;107(4):883-888.
5. Murakami I, Gogusev J, Fournet JC, Glorion C, Jaubert F. Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone. Hum Pathol 2002;33(5):555-560.
6. Betts DR, Leibundgut KE, Feldges A, Pluss HJ, Niggli FK. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer 1998;77(4):552-555.
7. Ornvold K, Carstensen H, Larsen JK, Christensen IJ, Ralfkiaer E. Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (histiocytosis X). Am J Pathol 1990; 136(6):1301-1307.
8. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, et al. Langerhans-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 1994;331(3):154-160.
9. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343(8900):767-768.
10. Bank MI, Rengtved P, Carstensen H, Petersen BL. Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 2003;111(2):300-308.
11. Bank MI, Gudbrand C, Rengtved P, Carstensen H, Fadeel B, Henter JI, et al. Immunohistochemical detection of the apoptosis-related proteins FADD, FLICE, and FLIP in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2005;27(6):301-306.
12. Schouten B, Egeler RM, Leenen PJ, Taminiau AH, van den Broek LJ, Hogendoorn PC. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2002; 24(9):727-732.
13. Petersen BL, Rengtved P, Bank MI, Carstensen H. High expression of markers of apoptosis in Langerhans cell histiocytosis. Histopathology 2003;42(2):186-193.
14. Oulton R, Harrington L. Telomeres, telomerase, and cancer: life on the edge of genomic stability. Curr Opin Oncol 2000; 12(1):74-81.
15. Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000;21(3):477-484.
16. Blackburn EH. Structure and function of telomeres. Nature 1991; 350(6319):569-573.
17. Zakian VA. Telomeres: beginning to understand the end. Science 1995;270(5242):1601-1607.
18. Reddel RR. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003;194(2):155-162.
19. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997;3(11):1271-1274.
20. Bryan TM, Cech TR. Telomerase and the maintenance of chromosome ends. Curr Opin Cell Biol 1999;11(3):318-324.
21. Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oncogene 2002;21(4):598-610.
22. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, et al. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 2005; 11(1):217-225.
23. Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, et al. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer 2004;41(2):155-162.
24. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 1995;75(5):1094-1099.
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266(5193):2011-2015.
26. Annels NE, da Costa CE, Prins FA, Willemze A, Hogendoorn PC, Egeler RM. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003;197(10):1385-1390.
27. Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, Lorimier P, et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 2004;90(6):1222-1229.
28. Corver WE, Ter Haar NT, Dreef EJ, Miranda NF, Prins FA, Jordanova ES, et al. High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues. J Pathol 2005;206(2):233-241.
29. Youssef N, Paradis V, Ferlicot S, Bedossa P. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J Pathol 2001;194(4):459-465.
30. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, et al. Telomerase activity in normal human epithelial cells. Oncogene 1996;13(2):433-439.
31. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18(2):173-179.
32. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997;90(1):192-193.
33. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33(5):787-791.
34. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92(20):9082-9086.
35. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155(8):3711-3715.
36. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 1999;163(6):3511-3515.